How often do you see this with a new drug/treatment.
I think they have found their initial niche. If you work in the medical profession in this particular area, this has to be a no brainer as a treatment. Aus market asleep at the wheel once again.
Ann: Patient Dosing Complete in Phase II ABSSSI Trial of R327G, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
32.5¢ |
Change
0.020(6.56%) |
Mkt cap ! $93.72M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 33.0¢ | 30.0¢ | $75.15K | 239.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10934 | 31.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.5¢ | 14999 | 1 |
View Market Depth
| Last trade - 16.10pm 17/06/2025 (20 minute delay) ? |
| RCE (ASX) Chart |